Antibiotic Incentive Bill Reintroduced: Industry Hopes for 2012 Enactment
The bill focuses on particularly virulent, resistant pathogens and also includes priority review designations and review of FDA guidelines.
The bill focuses on particularly virulent, resistant pathogens and also includes priority review designations and review of FDA guidelines.